HuCAR T Therapy

After CAR T therapy in March of 2021, Beaudin had full b-cell return by Day 28. We decided to move forward with the Humanized CAR T trial

In August 2021, Beaudin returned to Philadelphia for the HuCAR T infusion. That round of cells lasted for 4 months before the T cells began to fade in December 2022. He received a cell boost in January 2022 that was unsuccessful. We have chosen to take a “wait and watch” approach as he has been NED since right before the original CAR T in Spring 2021.

You can read about Car T therapy here and Humanized Car T therapy here.

Blog posts about HuCAR T, specifically can be found below. For all CAR T posts, please visit the page by the same name.